Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Itzhel García-Torres, Ignacio De la Mora-De la Mora, Gabriel López-Velázquez, Nallely Cabrera, Luis Antonio Flores-López, Ingeborg Becker, Juliana Herrera-López, Roberto Hernández, Ruy Pérez-Montfort & Sergio Enríquez-Flores. (2023) Repurposing of rabeprazole as an anti-Trypanosoma cruzi drug that targets cellular triosephosphate isomerase. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Nadiya Hussain, Muntaha Naeem & David J. Pinato. (2021) Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?. Human Vaccines & Immunotherapeutics 17:1, pages 55-61.
Read now
Read now
Miglė Paškevičiūtė & Vilma Petrikaitė. (2019) Proton Pump Inhibitors Modulate Transport Of Doxorubicin And Its Liposomal Form Into 2D And 3D Breast Cancer Cell Cultures. Cancer Management and Research 11, pages 9761-9769.
Read now
Read now
Emanuela Berrino & Claudiu T. Supuran. (2019) Novel approaches for designing drugs that interfere with pH regulation. Expert Opinion on Drug Discovery 14:3, pages 231-248.
Read now
Read now
Mariantonia Logozzi, Clemente Capasso, Rossella Di Raimo, Sonia Del Prete, Davide Mizzoni, Mario Falchi, Claudiu T. Supuran & Stefano Fais. (2019) Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 272-278.
Read now
Read now
Elisabetta Iessi, Mariantonia Logozzi, Luana Lugini, Tommaso Azzarito, Cristina Federici, Enrico Pierluigi Spugnini, Davide Mizzoni, Rossella Di Raimo, Daniela F. Angelini, Luca Battistini, Serena Cecchetti & Stefano Fais. (2017) Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1, pages 648-657.
Read now
Read now
Tomas Koltai. (2016) Cancer: fundamentals behind pH targeting and the double-edged approach. OncoTargets and Therapy 9, pages 6343-6360.
Read now
Read now
Khalid O. Alfarouk. (2016) Tumor metabolism, cancer cell transporters, and microenvironmental resistance. Journal of Enzyme Inhibition and Medicinal Chemistry 31:6, pages 859-866.
Read now
Read now
Cristina Federici, Luana Lugini, Maria Lucia Marino, Fabrizio Carta, Elisabetta Iessi, Tommaso Azzarito, Claudiu T. Supuran & Stefano Fais. (2016) Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells. Journal of Enzyme Inhibition and Medicinal Chemistry 31:sup1, pages 119-125.
Read now
Read now
Articles from other publishers (32)
Rong A, Haoyu Wang, Chaoqun Nie, Zhaoguo Han, Meifang Zhou, Olagbaju Oluwatosin Atinuke, Kaiqi Wang, Xiance Wang, Shuang Liu, Jingshi Zhao, Wenju Qiao, Xiaohong Sun, Lina Wu & Xilin Sun. (2023) Glycerol-weighted chemical exchange saturation transfer nanoprobes allow 19F/1H dual-modality magnetic resonance imaging-guided cancer radiotherapy. Nature Communications 14:1.
Crossref
Crossref
Tomas Koltai, Larry Fliegel, Fátima Baltazar, Stephan J. Reshkin, Khalid O. Alfarouk, Rosa Angela Cardone & Julieta Afonso. 2023. pH Deregulation as the Eleventh Hallmark of Cancer. pH Deregulation as the Eleventh Hallmark of Cancer
81
86
.
Saima Syeda, Kavita Rawat & Anju Shrivastava. (2022) Pharmacological Inhibition of Exosome Machinery: An Emerging
Prospect in Cancer Therapeutics. Current Cancer Drug Targets 22:7, pages 560-576.
Crossref
Crossref
Juanita Mathews, Franz Kuchling, David Baez-Nieto, Miranda Diberardinis, Jen Q. Pan & Michael Levin. (2022) Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma. Cancers 14:6, pages 1499.
Crossref
Crossref
Ganessan KichenadasseJohn O. Miners, Arduino A. Mangoni, Christos S. KarapetisAshley M. Hopkins & Michael J. Sorich. (2021) Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy. Journal of the National Comprehensive Cancer Network 19:9, pages 1037-1044.
Crossref
Crossref
Edgar Pérez-Herrero & Alberto Fernández-Medarde. (2021) The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers. Acta Pharmaceutica Sinica B 11:8, pages 2243-2264.
Crossref
Crossref
Kassidy A. Hebert, Sergio Jaramillo, Wangjie Yu, Min Wang, Ratna Veeramachaneni, Vlad C. Sandulache, Andrew G. Sikora, Mark D. Bonnen, Ananth V. Annapragada, David Corry, Farrah Kheradmand, Raj K. Pandita, Michelle S. Ludwig, Tej K. Pandita, Shixia Huang, Cristian Coarfa, Sandra L. Grimm, Dimuthu Perera, George Miles & Yohannes T. Ghebre. (2021) Esomeprazole enhances the effect of ionizing radiation to improve tumor control. Oncotarget 12:14, pages 1339-1353.
Crossref
Crossref
Shiori Hiromoto, Takehiro Kawashiri, Natsumi Yamanaka, Daisuke Kobayashi, Keisuke Mine, Mizuki Inoue, Mayako Uchida & Takao Shimazoe. (2021) Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome. Scientific Reports 11:1.
Crossref
Crossref
Xiaoxia Zhao, Ning Zhang, Yingying Huang, Xiaojing Dou, Xiaolin Peng, Wei Wang, Zhe Zhang, Ran Wang, Yuling Qiu, Meihua Jin & Dexin Kong. (2021) Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Peter W. Halcrow, Jonathan D. Geiger & Xuesong Chen. (2021) Overcoming Chemoresistance: Altering pH of Cellular Compartments by Chloroquine and Hydroxychloroquine. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Stefano Fais & Yoshinori Marunaka. (2020) The Acidic Microenvironment: Is It a Phenotype of All Cancers? A Focus on Multiple Myeloma and Some Analogies with Diabetes Mellitus. Cancers 12:11, pages 3226.
Crossref
Crossref
Michela Roberto, Adriana Romiti, Federica Mazzuca, Annalisa Milano, Chiara D’Antonio, Luana Lionetto, Rosa Falcone, Lidia Strigari, Maurizio Simmaco, Stefano Fais & Paolo Marchetti. (2020) Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial. Cancers 12:11, pages 3084.
Crossref
Crossref
Zhoulei Li, Peng He, Ganhua Luo, Xinchong Shi, Gang Yuan, Bing Zhang, Christof Seidl, Andreas Gewies, Yue Wang, Yuan Zou, Yali Long, Dianchao Yue & Xiangsong Zhang. (2020) Increased Tumoral Microenvironmental pH Improves Cytotoxic Effect of Pharmacologic Ascorbic Acid in Castration-Resistant Prostate Cancer Cells. Frontiers in Pharmacology 11.
Crossref
Crossref
Jian Feng, Tai Li, Shishao Liang, Chuanming Zhang, Xiaoyu Tan, Ning Ding, Xin Wang, Xiaoping Liu & Chun Hu. (2020) Synthesis and biological evaluation of a new series of 1-aryl-3-[4-(pyridin-2-ylmethoxy)phenyl]urea derivatives as new anticancer agents. Medicinal Chemistry Research 29:8, pages 1413-1423.
Crossref
Crossref
Aya Qasem, Violet Kasabri, Eman AbuRish, Yasser Bustanji, Yusuf Al-Hiari, Reem Al-Abbasi, Bashaer Abu-Irmaileh & Sundus Alalawi. (2020) The Evaluation of Potential Cytotoxic Effect of Different Proton Pump Inhibitors on Different Human Cancer Cell Lines. Anti-Cancer Agents in Medicinal Chemistry 20:2, pages 245-253.
Crossref
Crossref
Tomas Koltai, Stephan J. Reshkin & Salvador Harguindey. 2020. An Innovative Approach to Understanding and Treating Cancer: Targeting pH. An Innovative Approach to Understanding and Treating Cancer: Targeting pH
177
191
.
Tomas Koltai, Stephan J. Reshkin & Salvador Harguindey. 2020. An Innovative Approach to Understanding and Treating Cancer: Targeting pH. An Innovative Approach to Understanding and Treating Cancer: Targeting pH
53
97
.
Larry Fliegel. 2022. From Malignant Transformation to Metastasis. From Malignant Transformation to Metastasis
85
110
.
Alberto Foletti & Stefano Fais. (2019) Unexpected Discoveries Should Be Reconsidered in Science—A Look to the Past?. International Journal of Molecular Sciences 20:16, pages 3973.
Crossref
Crossref
Miglė Paškevičiūtė & Vilma Petrikaitė. (2018) Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades. Drug Delivery and Translational Research 9:1, pages 379-393.
Crossref
Crossref
Elisabetta Iessi, Mariantonia Logozzi, Davide Mizzoni, Rossella Di Raimo, Claudiu Supuran & Stefano Fais. (2017) Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy. Metabolites 8:1, pages 2.
Crossref
Crossref
Zhen-Ning Lu, Bing Tian & Xiu-Li Guo. (2017) Repositioning of proton pump inhibitors in cancer therapy. Cancer Chemotherapy and Pharmacology 80:5, pages 925-937.
Crossref
Crossref
Claudiu T. Supuran. (2017) Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors. Metabolites 7:3, pages 48.
Crossref
Crossref
Veronica Huber, Chiara Camisaschi, Angela Berzi, Simona Ferro, Luana Lugini, Tiziana Triulzi, Alessandra Tuccitto, Elda Tagliabue, Chiara Castelli & Licia Rivoltini. (2017) Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation. Seminars in Cancer Biology 43, pages 74-89.
Crossref
Crossref
Enrico Spugnini & Stefano Fais. (2017) Proton pump inhibition and cancer therapeutics: A specific tumor targeting or it is a phenomenon secondary to a systemic buffering?. Seminars in Cancer Biology 43, pages 111-118.
Crossref
Crossref
Hans-Peter Lipp. (2017) Supportivtherapeutika und Onkologika. Im Focus Onkologie 20:1-2, pages 44-49.
Crossref
Crossref
Carmelo Scarpignato, Luigi Gatta, Angelo Zullo & Corrado Blandizzi. (2016) Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression. BMC Medicine 14:1.
Crossref
Crossref
Eduardo Chueca, Nadezda Apostolova, Juan V. Esplugues, María A. García-González, Ángel Lanas & Elena Piazuelo. (2016) Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells. Frontiers in Pharmacology 7.
Crossref
Crossref
Tommaso Azzarito, Luana Lugini, Enrico Pierluigi Spugnini, Rossella Canese, Alessio Gugliotta, Stefano Fidanza & Stefano Fais. (2016) Effect of Modified Alkaline Supplementation on Syngenic Melanoma Growth in CB57/BL Mice. PLOS ONE 11:7, pages e0159763.
Crossref
Crossref
Andrea Canitano, Elisabetta Iessi, Enrico Pierluigi Spugnini, Cristina Federici & Stefano Fais. (2016) Proton pump inhibitors induce a caspase-independent antitumor effect against human multiple myeloma. Cancer Letters 376:2, pages 278-283.
Crossref
Crossref
Stefano Fais. (2015) Evidence-based support for the use of proton pump inhibitors in cancer therapy. Journal of Translational Medicine 13:1.
Crossref
Crossref
Sophie Taylor, Enrico Pierluigi Spugnini, Yehuda G. Assaraf, Tommaso Azzarito, Cyril Rauch & Stefano Fais. (2015) Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. Drug Resistance Updates 23, pages 69-78.
Crossref
Crossref